328
Participants
Start Date
July 31, 2012
Primary Completion Date
March 31, 2013
Study Completion Date
June 30, 2013
BioThrax®
BioThrax® is a sterile, milky white suspension made from cell free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis, will be administered as a 0.50mL IM injection 6 month boost for all groups
BioThrax®
BioThrax® will be administered as: Arm A: 0.50mL SC injection on Days 0 and 14; Arm B: 0.50mL SC injection on Days 0 and 28; Arm C: 0.50mL SC injection on Days 0, 14 and 28; Arm D: 0.25 mL SC injection on Days 0, 14 and 28.
Emory Children's Center - Pediatric Infectious Diseases, Atlanta
Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati
Baylor College of Medicine - Molecular Virology and Microbiology, Houston
Group Health Research Institute - Seattle, Seattle
National Institute of Allergy and Infectious Diseases (NIAID)
NIH